Cyanokit (Meridian Medical Technologies, Inc.)


Welcome to the PulseAid listing for the Cyanokit drug offered from Meridian Medical Technologies, Inc.. This Antidote [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Meridian Medical Technologies, Inc.
NON-PROPRIETARY NAME: hydroxocobalamin
SUBSTANCE NAME: HYDROXOCOBALAMIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antidote [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-10-01
END MARKETING DATE: 0000-00-00


Cyanokit HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCyanokit from Meridian Medical Technologies, Inc.
LABELER NAME: Meridian Medical Technologies, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(g/250mL)
START MARKETING DATE: 2011-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 11704-370_cec4e9a9-b971-4a05-bde5-a1ad7ac37e24
PRODUCT NDC: 11704-370
APPLICATION NUMBER: NDA022041

Other HYDROXOCOBALAMIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Meridian Medical Technologies, Inc.Cyanokit